ROCKVILLE, Md., Dec. 13, 2010 /PRNewswire/ -- Clinical trial patient recruitment and retention organization MMG recently received a 2010 National Institute of Health Merit Award from National Cancer Institute director Harold Varmus for its work in support of the Smokefree Women campaign. The award recognizes the Smokefree Women team for its application of research, creativity and dedication to making the Smokefree Women campaign a success.
Specifically, the merit award recognizes MMG's Smokefree Women team for excellence in applying smoking cessation research findings to the development of the www.women.smokefree.gov website and other social media platforms to help women quit smoking.
The www.women.smokefree.gov website is an interactive community dedicated to helping women find their own personal way to quit smoking. The Smokefree Women campaign includes the website, a YouTube channel, a Facebook page and a Twitter feed. Resources are also available via live chat or phone (1-877-44U-QUIT) from counselors who can answer specific questions and help women design a personalized quit plan.
The Smokefree Women YouTube channel has had more than 2,000 views of its video announcement for the "Celebrating Smokefree Voices" contest held in May 2010. Smokefree Women has also begun incorporating Facebook video blogs to engage its target audience.
"We are delighted that our audience has responded so enthusiastically to our use of emerging technologies and platforms," said MMG's Shani C. Taylor, project manager for the Smokefree Women campaign. "Winning this award encourages us to continue exploring new ways to deliver resources to women who are trying to quit smoking."
MMG's Smokefree Women team members recognized include Mary Schwarz, vice president, core services and operations; Shani C. Taylor, M.H.S., project manager; Alison Pilsner, M.P.H., C.H.E.S, C.P.H, e-health ambassador; and Lewellyn Belber, manager, development services.
The primary objective of the National Cancer Institute's NIH Merit Award is to recognize the outstanding contributions of groups and individuals that aid in the continued advancement of cancer research and dissemination of research findings.
MMG, a Ketchum company and part of the Omnicom Group (NYSE: OMC) family, is the premier global clinical trial patient recruitment and retention organization. With experience in more than 70 countries and deep insights across therapeutic areas, patient populations and study types, MMG designs and executes strategic programs to increase and accelerate clinical trial participation for pharmaceutical industry and government-sponsored research.